This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tillotts Pharma Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yalcin Cetinkaya-Coskun: Innovator in Modified Release Drug Formulation
Introduction
Yalcin Cetinkaya-Coskun is a notable inventor based in Rheinfelden, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug formulations. His innovative work focuses on creating effective methods for oral drug administration.
Latest Patents
Yalcin holds a patent for a "Coatable core for a modified release drug formulation." This patent describes a method for producing a coatable core that allows for a high drug load of at least 70 wt % based on the total weight of the core. The method involves granulating a composition containing a drug and at least one binder to form granules. These granules are then blended with a pharmacologically acceptable disintegrant and optionally, additional excipients, to create a compression blend. The final step involves compressing this blend using an external lubrication compression method to form the coatable core.
Career Highlights
Yalcin is currently associated with Tillotts Pharma AG, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficacy of drug formulations, thereby contributing to improved patient outcomes.
Collaborations
Yalcin collaborates with several professionals in his field, including Thomas Buser and Roberto Carlos Bravo González. These collaborations foster innovation and drive advancements in pharmaceutical technology.
Conclusion
Yalcin Cetinkaya-Coskun is a prominent figure in the pharmaceutical industry, recognized for his innovative approaches to drug formulation. His contributions are paving the way for more effective oral drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
